MicroRNAs as Diagnostic and Prognostic Biomarker of Alzheimer's Disease

$2,066,213RF1FY2022AGNIH

Boston University Medical Campus, Boston MA

Investigators

Ivana Delallecontact Jan Krzysztof Blusztajn Andre Fischer

Linked publications & trials

Paper 39291752 Paper 39291737 Paper 39207536 Paper 39005272 Paper 38315685 Paper 37718815 Paper 36812208

View original record on NIH RePORTER →